RSS Feed For (NASDAQ:QGLY)

QUIGLEY (NASDAQ:QGLY)

2.29 +0.14 (6.51%)
QUIGLEY (NASDAQ:QGLY) Delayed :
Previous Close $2.15    52 Week High $6.70 
Open $2.15    52 Week Low $1.58 
Day High $2.30    P/E N/A 
Day Low $2.15    EPS $-0.59 
Volume 1,615       
More QGLY Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
NVAX 2 NVAX 2
HEB 1 TSEM 1
EPM 1 NAFC 1
WPRT 1 VICL 1
BCH 1 ICXT 1
RLOG 1 CRXL 1
View All Friends, Peers and Foes

StreetInsider.com Major News for QGLY

Nov 12, 2009 08:37 AM Quigley (QGLY) Posts Q3 Loss of 9c, Down Y/Y; Revs Lower

StreetInsider Reports on QGLY by Category

View All FilingsSEC Filings on QGLY

Nov 13, 2009 01:55PM Form 10-Q QUIGLEY CORP For: Sep 30
Oct 22, 2009 05:04PM Form 8-K QUIGLEY CORP For: Oct 21
View All Filings

Comments on recent QGLY articles

Jonathan P
on Aug 18, 2009
at 11:42 PM
Quigley's new board They ruined a small town "family" business in this proxy battle an don't let this guy Karkus snow the public. For all his complaining about executive compensation, he's taking $750,000 a year and being a new yorker probably isn't there every day. What a sham!
Article: Quigley Corporation (QGLY) Names Ted Karkus as CEO
Tony C
on Apr 28, 2009
at 09:13 AM
money makers that will save- prolong life provectus pharma pvct another cancer cure +++ dandrion DNDN jump on board
Article: U.S. Issues Public Health Emergency About Swine Flu
natalia
on Apr 27, 2009
at 10:40 PM
i see what you mean that stock finished up over 18% for the day on big volume. that's a much bigger gain than most of those stocks mentioned by hot list - and it was much higher earlier in the day. http://cxa.marketwatch.com/tsx/en/market/quote.aspx?symbol=rbm
Article: U.S. Issues Public Health Emergency About Swine Flu
Peter H
on Apr 27, 2009
at 10:16 PM
3M Rapid Detection Flu A+B Test I am surprised that this article didn't mention Response Biomedical (TSX: RBM), which makes the rapid flu test marketed by 3M as the 3M Rapid Detection Flu A + B Test. It was just launched in the fall and is a more accurate and sophisticated test than the other point of care tests on the market, like Quidel. By the way, RBM is also partnered with Roche (maker of Tamiflu) in an agreement to supply all of Roche's point of care cardiology tests and Cardiac Readers, which just launched in March of April.
Article: U.S. Issues Public Health Emergency About Swine Flu

Comments on QGLY


No comments are currently available.